A phase I dose-escalation and expansion study evaluating the safety and efficacy of the MDM2-p53 antagonist BI 907828 in patients (pts) with solid tumours Meeting Abstract
| Authors: | Schoeffski, P.; Yamamoto, N.; Bauer, T.; Patel, M.; Gounder, M. M.; Geng, J.; Sailer, R.; Jayadeva, G.; Lorusso, P. |
| Abstract Title: | A phase I dose-escalation and expansion study evaluating the safety and efficacy of the MDM2-p53 antagonist BI 907828 in patients (pts) with solid tumours |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S743 |
| Language: | English |
| ACCESSION: | WOS:000866211600446 |
| DOI: | 10.1016/j.annonc.2022.07.581 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 452O -- Source: Wos |
